Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation

Published:2012-06 Issue:6 Volume:18 Page:913-921
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

van Besien Koen,Stock Wendy,Rich Elizabeth,Odenike Olatoyosi,Godley Lucy A.,O’Donnell Peter H.,Kline Justin,Nguyen Vu,del Cerro Paula,Larson Richard A.,Artz Andrew S.

Funder

Genzyme Corp

Genzyme Corporation

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference49 articles.

1. Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS;Luger;Bone Marrow Transplant,2011

2. Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared with myeloablative conditioning;Hari;Biol Blood Marrow Transplant,2008

3. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation;Giralt;Blood,2001

4. Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome;van Besien;J Clin Oncol,2005

5. T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed lymphoma. Predictors for survival after transplant relapse;Kenkre;Leuk Lymphoma,2011

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review;Current Cancer Therapy Reviews;2024-01

2. Transplantation;Clinical Immunology;2023

3. Nephrotoxicity in cancer treatment: An overview;World Journal of Clinical Oncology;2020-04-24

4. Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II Trial;Biology of Blood and Marrow Transplantation;2020-02

5. Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults;Blood Advances;2019-11-14